I. Auwera

发表

Clinicopathological Analysis of Lymphatic Vessels and of Lymphangiogenesis in Human Cancer

P. Vermeulen, L. Dirix, I. V. D. Auwera, 2009 .

First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours

S. Fox, A. Harris, I. Van der Auwera, 2006, British Journal of Cancer.

Differential expression of hypoxia and (lymph)angiogenesis-related genes at different metastatic sites in breast cancer

Luc Y. Dirix, Peter B. Vermeulen, P. Dam, 2007, Clinical & Experimental Metastasis.

Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis

E. van Marck, P. V. van Dam, G. G. Van den Eynden, 2007, British Journal of Cancer.

Distinct Molecular Signature of Inflammatory Breast Cancer by cDNA Microarray Analysis

Luc Y. Dirix, Stephen B. Fox, Adrian L. Harris, 2005, Breast Cancer Research and Treatment.

Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype

I. Van der Auwera, R. Limame, P. van Dam, 2010, British Journal of Cancer.

Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia

E. van Marck, A. Harris, R. Salgado, 2004, British Journal of Cancer.

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer

P. V. van Dam, D. Peeters, I. Van der Auwera, 2009, British Journal of Cancer.

The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients

E. van Marck, P. V. van Dam, I. Van der Auwera, 2009, British Journal of Cancer.

Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype

B. X. Trinh, E. van Marck, P. V. van Dam, 2008, British Journal of Cancer.

The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer

E. Berns, P. V. van Dam, G. G. Van den Eynden, 2009, British Journal of Cancer.

Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer

S. Merajver, P. Dam, P. Vermeulen, 2006, Breast Cancer Research and Treatment.

NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation

E. van Marck, P. V. van Dam, G. G. Van den Eynden, 2007, British Journal of Cancer.

Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study

E. van Marck, P. V. van Dam, C. Colpaert, 2006, British Journal of Cancer.

Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling

P. Dam, P. Vermeulen, L. Dirix, 2006, Breast Cancer Research and Treatment.

Validation of a Tissue Microarray to Study Differential Protein Expression in Inflammatory and Non-Inflammatory Breast Cancer

S. Merajver, E. van Marck, A. Harris, 2004, Breast Cancer Research and Treatment.

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer

D. Peeters, P. Huget, A. Prové, 2009, British Journal of Cancer.

Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer

E. van Marck, P. V. van Dam, C. Colpaert, 2006, British Journal of Cancer.

Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer

E. van Marck, A. Harris, P. V. van Dam, 2005, British Journal of Cancer.

Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype

L. Dirix, Peter B. Vermeulen, I. Auwera, 2010, British Journal of Cancer.